The economic burden of complications occurring in major surgical procedures: A systematic review

Applied Health Economics and Health Policy

Volumn 11, Issue 6, 2013, Pages 577-592

  Patel, Ajay S ^a   Bergman, Annika ^b   Moore, Brigitte W ^a   Haglund, Ulf ^c  

^a Decision Resources Group   (United Kingdom)

^b Takeda Pharmaceuticals International GmbH   (Switzerland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIURIA; CARDIOVASCULAR DISEASE; CYSTOVAGINAL FISTULA; DISEASE SEVERITY; ECONOMIC BURDEN; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC SURGERY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION COST; HUMAN; KIDNEY DISEASE; LIVER SURGERY; LUNG DISEASE; LYMPHOCELE; MAJOR SURGERY; OUTCOME ASSESSMENT; PANCREAS SURGERY; PEROPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RATING SCALE; RECTUM INJURY; REVIEW; SURGICAL INFECTION; SYSTEMATIC REVIEW; THORAX SURGERY; UROLOGIC SURGERY; WOUND;

COSTS AND COST ANALYSIS; HEALTH RESOURCES; HUMANS; INTRAOPERATIVE COMPLICATIONS; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, OPERATIVE;

EID: 84890509422     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-013-0060-y     Document Type: Review

References (70)

1. Bundesamt für Statistik. Kosten des Gesundheitswesens; 2010. Available from: http://www.bfs.admin.ch/bfs/portal/de/index/themen/14/05/blank/ key/ueberblick.html. Accessed Nov 2012.
2. Institut national de la statistique et des études économiques. Depense courante de santé en; 2011. Available from: http://www.insee.fr/fr/themes/tableau.asp?reg-id=0&ref-id=NATTEF06305. Accessed Nov 2012.
3. Centers for Medicare & Medicaid Services. National health expenditure projections 2011-2021. Available from: http://www.cms.gov/Research-Statistics- Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/ Downloads/Proj2011PDF.pdf. Accessed Jun 2013.
4. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491-507.
5. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
6. Ergina PL, Cook JA, Blazeby JM, et al. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097-104.
7. Barkun JS, Aronson JK, Feldman LS, et al. Evaluation and stages of surgical innovations. Lancet. 2009;374:1089-96.
8. McCulloch P, Altman DG, Campbell WB, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105-12.
9. Vonlanthen R, Slankamenac K, Breitenstein S, et al. The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg. 2011;254:907-13.
10. Handy JR Jr, Denniston K, Grunkemeier GL, et al. What is the inpatient cost of hospital complications or death after lobectomy or pneumonectomy? Ann Thorac Surg. 2011;91:234-8.
11. Yu HY, Hevelone ND, Lipsitz SR, et al. Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol. 2012;187:1632-7.
12. Nagel M, Gemmen E, Smith B, et al. Assessment of the clinical and economic impact of air leaks during post-operative pulmonary surgery. Presented at the 2010 15th annual International Society for Pharmacoeconomics and Outcomes research meeting, PRS18; 2010.
13. Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg. 2012;78:1305-21.
14. Spotnitz WD, Burks S. State-of-the-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost. 2010;16:497-514.
15. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion. 2012;52:2243-55.
16. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011.
17. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-96.
18. Breitenstein S, DeOliveira ML, Raptis DA, et al. Novel and simple preoperative score predicting complications after liver resection in noncirrhotic patients. Ann Surg. 2010;252:726-34.
19. Daskalaki D, Butturini G, Molinari E, et al. A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. Langenbecks Arch Surg. 2011;396:91-8.
20. Kent TS, Sachs TE, Callery MP, et al. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213:515-23.
21. Pratt WB, Callery MP, Vollmer CM Jr. The latent presentation of pancreatic fistulas. Br J Surg. 2009;96:641-9.
22. Rodriguez JR, Germes SS, Pandharipande PV, et al. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg. 2006;141:361-5; discussion 66.
23. Topal B, Peeters G, Vandeweyer H, et al. Hospital cost-categories of pancreaticoduodenectomy. Acta Chir Belg. 2007;107:373-7.
24. Vanounou T, Pratt WB, Callery MP, et al. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands. J Am Coll Surg. 2007;205:546-57.
25. Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect. 2005;60:93-103.
26. de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37:387-97.
27. Gunnarsson C, Rizzo JA, Hochheiser L. The effects of laparoscopic surgery and nosocomial infections on the cost of care: evidence from three common surgical procedures. Value Health. 2009;12:47-54.
28. Rotermann M. Infection after cholecystectomy, hysterectomy or appendectomy. Health Rep. 2004;15:11-23.
29. Pilling JE, Martin-Ucar AE, Waller DA. Salvage intensive care following initial recovery from pulmonary resection: is it justified? Ann Thorac Surg. 2004;77:1039-44.
30. Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130:438-44.
31. Varela G, Jimenez MF, Novoa N, et al. Estimating hospital costs attributable to prolonged air leak in pulmonary lobectomy. Eur J Cardiothorac Surg. 2005;27:329-33.
32. Rapoport J, Teres D, Lemeshow S, et al. Explaining variability of cost using a severity-of-illness measure for ICU patients. Med Care. 1990;28:338-48.
33. Casadei R, Ricci C, Pezzilli R, et al. Assessment of complications according to the Clavien-Dindo classification after distal pancreatectomy. JOP. 2011;12:126-30.
34. Jimenez RE, Mavanur A, Macaulay WP. Staple line reinforcement reduces postoperative pancreatic stump leak after distal pancreatectomy. J Gastrointest Surg. 2007;11:345-9.
35. Seely AJ, Ivanovic J, Threader J, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg. 2010;90:936-42; discussion 42.
36. Stolz AJ, Schutzner J, Lischke R, et al. Predictors of prolonged air leak following pulmonary lobectomy. Eur J Cardiothorac Surg. 2005;27:334-6.
37. Behrman SW, Zarzaur BL. Intra-abdominal sepsis following pancreatic resection: incidence, risk factors, diagnosis, microbiology, management, and outcome. Am Surg. 2008;74:572-8; discussion 78-9.
38. Belyaev O, Munding J, Herzog T, et al. Histomorphological features of the pancreatic remnant as independent risk factors for postoperative pancreatic fistula: a matched-pairs analysis. Pancreatology. 2011;11:516-24.
39. Fuks D, Piessen G, Huet E, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009;197:702-9.
40. Glowka TR, Kalff JC, Pantelis D, et al. Secondary surgery subsequent to distal pancreatectomy. Hepatogastroenterology. 2010;57:952-6.
41. Haddad LB, Scatton O, Randone B, et al. Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choice. HPB (Oxford). 2009;11:203-9.
42. Simons JP, Shah SA, Ng SC, et al. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. 2009;13:1798-805.
43. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
44. Bartsch GC, Kuefer R, Braun C, et al. Nosocomial bacteriuria in patients with indwelling catheter after radical retropubic prostatectomy for prostate cancer. Urol Int. 2008;81:389-93.
45. Guillonneau B, Gupta R, El Fettouh H, et al. Laparoscopic [correction of laproscopic] management of rectal injury during laparoscopic [correction of laproscopic] radical prostatectomy. J Urol. 2003;169:1694-6.
46. Treiyer A, Haben B, Stark E, et al. Uni- vs. multiloculated pelvic lymphoceles: differences in the treatment of symptomatic pelvic lymphoceles after open radical retropubic prostatectomy. Int Braz J Urol. 2009;35:164-9; discussion 70.
47. Aaronson DS, Wu AK, Blaschko SD, et al. National incidence and impact of noninfectious urethral catheter related complications on the Surgical Care Improvement Project. J Urol. 2011;185:1756-60.
48. Duong TH, Gellasch TL, Adam RA. Risk factors for the development of vesicovaginal fistula after incidental cystotomy at the time of a benign hysterectomy. Am J Obstet Gynecol. 2009;201(512):e1-4.
49. Antanavicius G, Lamb J, Papasavas P, et al. Initial chest tube management after pulmonary resection. Am Surg. 2005;71:416-9.
50. Bardell T, Petsikas D. What keeps postpulmonary resection patients in hospital? Can Respir J. 2003;10:86-9.
51. Dulu A, Pastores SM, Park B, et al. Prevalence and mortality of acute lung injury and ARDS after lung resection. Chest. 2006;130:73-8.
52. Ghosh S, Steyn RS, Marzouk JF, et al. The effectiveness of high dependency unit in the management of high risk thoracic surgical cases. Eur J Cardiothorac Surg. 2004;25:123-6.
53. Ishikawa S, Griesdale DE, Lohser J. Acute kidney injury after lung resection surgery: incidence and perioperative risk factors. Anesth Analg. 2012;114:1256-62.
54. Liberman M, Muzikansky A, Wright CD, et al. Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis. Ann Thorac Surg. 2010;89:891-7; discussion 97-8.
55. Okereke I, Murthy SC, Alster JM, et al. Characterization and importance of air leak after lobectomy. Ann Thorac Surg. 2005;79:1167-73.
56. Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg. 2012;215:322-30.
57. Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs: same or different? Value Health. 2009;12:402-4.
58. Association of Surgeons of Great Britain, Royal College of Surgeons in Ireland. Consensus statement on cost-effective and sustainable Surgery; 2012. Available from: http://www.asgbi.org.uk/en/publications/consensus-statements. cfm. Accessed Apr 2013.
59. Association of Surgeons of Great Britain and Ireland. Issues in professional practice: guidelines for implementation of enhanced recovery protocols; 2009. Available from: http://www.asgbi.org.uk/en/publications/issues- in-professional-practice.cfm. Accessed Apr 2013.
60. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43:322-30.
61. Fitzgerald J, Kanter G, Trelease R, et al. Reducing surgical complications. Nurs Manag. 2007;38:35-9.
62. National Institute for Health and Clinical Excellence. CG74: surgical site infection - prevention and treatment of surgical site infection; 2008. Available from: http://www.nice.org.uk/nicemedia/pdf/CG74NICEGuideline.pdf. Accessed Apr 2013.
63. American College of Surgeons National Surgical Quality Improvement Program. About ACS NSQIP. Available from: http://site.acsnsqip.org/about/. Accessed Apr 2013.
64. Hall BL, Hamilton BH, Richards K, et al. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. Ann Surg. 2009;250:363-76.
65. Tennessee Surgical Quality Collaborative. Available from: http://www.tnsqc.com/. Accessed Apr 2013.
66. Guillamondegui OD, Gunter OL, Hines L, et al. Using the National Surgical Quality Improvement Program and the Tennessee Surgical Quality Collaborative to improve surgical outcomes. J Am Coll Surg. 2012;214:709-14; discussion 14-6.
67. Eappen S, Lane BH, Rosenberg B, et al. Relationship between occurrence of surgical complications and hospital finances. JAMA. 2013;309:1599-606.
68. Krupka DC, Sandberg WS, Weeks WB. The impact on hospitals of reducing surgical complications suggests many will need shared savings programs with payers. Health Aff (Millwood). 2012;31:2571-8.
69. Hashimoto Y, Traverso LW. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010;147:503-15.
70. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.